Target intelligence / Profile preview

PRELI domain containing protein 3A (PRELID3A)

Target
PRELID3A
Molecular classification
Lipid transfer protein, Mitochondrial protein, Other
01

Overview

PRELI domain containing protein 3A (PRELID3A) is a mitochondrial lipid transfer protein that enables the transfer of phosphatidic acid (PA) between membranes, particularly across the mitochondrial intermembrane space[1][3][4][5][10]. By forming a complex with the partner protein TRIAP1, PRELID3A facilitates the critical import of phosphatidic acid required for cardiolipin synthesis in the mitochondrial inner membrane[4][8]. Structural studies demonstrate that the PRELI domain forms a lipid-binding cavity that is essential for regulated lipid transfer[2][6]. PRELID3A localizes to the mitochondria and is essential for maintaining mitochondrial membrane structure and integrity through its role in phospholipid transport[2][4][8][10]. No direct information on clinically approved drugs, disease biomarker roles, or known safety concerns is available in current references; PRELID3A is primarily a fundamental component of mitochondrial lipid metabolism rather than a conventional therapeutic target[2][4].

Other names
PRELI domain containing 3AC18orf43SLMO1HFL-EDDG1FLJ31484Protein slowmo homolog 1erythroid differentiation and denucleation factor 1
02

Biological functions

Phosphatidic acid transfer activityPhospholipid transport in mitochondriaMaintenance of mitochondrial membrane composition and integrityCardiolipin synthesis (indirectly via PA transfer)
03

Disease associations

Other (altered mitochondrial lipid metabolism may impact cellular health, but no clear direct implication in major diseases such as cancer or neurodegenerative disorders is established in current literature)

Beyond the preview

Go deeper on PRELI domain containing protein 3A (PRELID3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing protein 3A (PRELID3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call